07-30-2008: Seegene, Inc. and Shimadzu Corporation announced a strategic partnership to combine Seegene's Seeplex(R) multi-pathogen tests with Shimadzu's MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction-based tests with Shimadzu's MultiNA high-speed electrophoresis system to provide a highly sensitive, high-throughput multi-pathogen detection and analysis solution.
"This strategic agreement reinforces our plan to bring solutions, and not only products, to our customers," said Dr. Jong-Yoon Chun, Founder and Chief Executive Officer, Seegene. "Shimadzu's MultiNA is outstanding in the market for electrophoresis analysis and a perfect match for the Seeplex family of multi-pathogen tests."
"Seegene's novel multi-pathogen detection test working with Shimadzu's next-generation electrophoresis systems creates an unparalleled screening platform for laboratories around the world," said Yoshiyuki Togawa, General Manager, Shimadzu. "Seeplex tests running on MultiNA is the fast, accurate and efficient way for laboratories to screen for the most rampant and debilitating pathogens infecting people around worldwide."
Shimadzu Scientific Instruments Inc. (SSI) is now offering a new white paper titled “Advantages of LCMS-IT-TOF Mass Spectrometry in Identifying Polymer Additives.” The paper is available for free download at the company’s Web site.
Identifying polymer additives is a critical step for produ ... more
Shimadzu has been awarded the 2008 Frost & Sullivan European Mass Spectrometry Product Line Strategy Award. It is presented each year to a company that has demonstrated the most insight into customer needs and product demands. The recipient company should have optimized its product line by ... more
Seegene, Inc. and Shimadzu Corporation announced a strategic partnership to combine Seegene's Seeplex(R) multi-pathogen tests with Shimadzu's MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction- ... more
1st July 2006 is an important deadline for the electro- and electronics industries. This date bans hazardous substances like lead, cadmium, mercury, hexavalent chromium and polybrominated biphenyls and diphenyl ethers from electro- and electronic equipment. This restriction, even though in ... more
Identification of organic pollutants in wastewater is essential for performance evaluation, construction and operation of a wastewater treatment plant. Several parameters are currently used in wastewater analysis applications. The advantages of TOC analyses are apparent especially during co ... more
Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens.
"The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapi ... more
Seegene, Inc announced that it has been awarded international patent protection for a break-through technology able to accelerate the detection of highly personal variations in genetic sequences. These genetic variations can identify an individual's risks for a broad range of disorders, suc ... more
Seegene, Inc. and Shimadzu Corporation announced a strategic partnership to combine Seegene's Seeplex(R) multi-pathogen tests with Shimadzu's MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction- ... more